PATENT CLAIM ANALYSIS

Application Number: 15769864
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-11
Patent Classification: ["514", "016600"]

Abstract:
The present invention relates to amino acid sequences that are directed against IL-23. The amino acid sequences of the present invention comprise two Nanobodies against IL-23 and one Nanobody against serum albumin, linked by two linkers (9GS linkers). In particular, the invention relates to the amino acid sequences of SEQ ID NO: 2 and SEQ ID NO: 3 (listed in Table 1 and FIG.  1 ) (also referred to herein as “anti-IL 23 polypeptides of the invention”).

Claim (Index 6):
A method for preventing or treating inflammation and inflammatory disorders such as bowel diseases (colitis, Crohn's disease, IBD), infectious diseases, psoriasis, cancer, autoimmune diseases (such as MS), sarcoidosis, transplant rejection, cystic fibrosis, asthma, chronic obstructive pulmonary disease, rheumatoid arthritis, viral infection, common variable immunodeficiency, comprising administering to a subject in need of such treatment a prophylactic or therapeutically active amount of polypeptide according to  claim 1 .

Metadata:
- Claim Count in Document: 7.0
- Percentile: 91.0
- Lexical Diversity: 1.73585
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15501011', '15456824', '15317188', '14922630', '15317633']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7008171289373745
- 35 USC 102 Novelty (BERT): 0.490313400357403
- Combined Prediction Score: 0.6797667560793773
- Mean Citation Score: 187.13611
- Max Citation Score: 195.08955
- Similarity Product: 143.18185087994638

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test